𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Betting on immunotherapy for melanoma

✍ Scribed by Mario Sznol

Book ID
107546701
Publisher
Current Science Inc.
Year
2009
Tongue
English
Weight
298 KB
Volume
11
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Immunotherapy for metastatic melanoma
Immunotherapy for metastatic melanoma
✍ Christopher R. Zito; Harriet M. Kluger πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 118 KB

## Abstract Melanoma has traditionally been considered an immunogenic tumor. A number of approaches have been studied for enhancement of antitumor immunity. The first cytokine approved for the treatment of metastatic melanoma, interleukin‐2, has resulted in prolonged responses in a small subset of

Adjuvant immunotherapy for melanoma
Adjuvant immunotherapy for melanoma
✍ L. J. Humphrey; S. Taschler-Collins; P. M. Coldfarb; O. Sincla; F. J. Volenec πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 282 KB

Adjuvant immunotherapy was administered to 84 lymph-node-negative and 25 lymph-node-positive melanoma patients. This active specific homologous cell protein preparation was given after aggressive surgery and given over 2 years. Projected and observed survival rates are presented as well as other cli

BCG immunotherapy for recurrent malignan
BCG immunotherapy for recurrent malignant melanoma
✍ Shelley L. Rasmussen; Jordan U. Gutterman; Evan M. Hersh; Sydney Boston; M. Mars πŸ“‚ Article πŸ“… 1980 πŸ› Springer-Verlag 🌐 English βš– 789 KB

A study was made of immunologic parameters obtained from patients with stage IIIB malignant melanoma who were treated with BCG. Patients with the longest disease-free interval and survival times were those who had small initial skin test reactions and developed larger reactions during the course of